Published • loading... • Updated
BlackRock Inc. Makes New Investment in Cytek Biosciences, Inc. $CTKB
Summary by MarketBeat
1 Articles
1 Articles
BlackRock Inc. Makes New Investment in Cytek Biosciences, Inc. $CTKB
BlackRock Inc. acquired a new stake in Cytek Biosciences, Inc. (NASDAQ:CTKB - Free Report) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 9,578,643 shares of the company's stock, valued at approx
·Sioux Falls, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
